Compile Data Set for Download or QSAR
Report error Found 277 Enz. Inhib. hit(s) with all data for entry = 2987
TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387442BDBM387442(US10294212, No. 76 | 7-Ethyl-N3-(3- (trifluoro- me...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387440BDBM387440(US10294212, No. 74 | 7-Ethyl-N3-(4- fluoro-3- (tri...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387438BDBM387438(US10294212, No. 73 | N3-(3-Chloro-4- fluorophenyl)...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387429BDBM387429(US10294212, No. 64 | N3-(3-Chloro-4- fluorophenyl)...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387431BDBM387431(US10294212, No. 153 | N3-(3-Chloro-4- fluorophenyl...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387430BDBM387430(US10294212, No. 65 | N3-(3- (Difluoro- methyl) phe...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387453BDBM387453(US10294212, No. 86 | 7-Benzyl-N3-(3- chloro-4- flu...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387452BDBM387452(N3-(3-Chloro-4- fluorophenyl)- 5-methoxy-7- methyl...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387460BDBM387460(US10294212, No. 92 | N3-(3- Ethynylphenyl)- 7- phe...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387459BDBM387459(US10294212, No. 91 | N3-(3-Chloro-4- fluorophenyl)...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387458BDBM387458(US10294212, No. 90 | N3-(3-Chloro-4- fluorophenyl)...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387446BDBM387446(US10294212, No. 80 | 7-Methyl-N3- (3-(trifluoro- m...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387445BDBM387445(US10294212, No. 79 | N3-(4-Fluoro-3- (trifluoro- m...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387444BDBM387444(US10294212, No. 78 | 7-Propyl-N3-(3- (trifluoro- m...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387443BDBM387443(US10294212, No. 77 | N3-(3-Chloro-4- fluorophenyl)...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387449BDBM387449(US10294212, No. 83 | N3-(3-Chloro-4- fluorophenyl)...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387448BDBM387448(US10294212, No. 82 | 7-Phenyl-N3- (3-(trifluoro- m...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387447BDBM387447(US10294212, No. 81 | N3-(3-Chloro-4- fluorophenyl)...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387478BDBM387478(US10294212, No. 103 | 2-Amino-3-((3- chloro-4- flu...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387474BDBM387474(US10294212, No. 101 | N3-(3-Chloro-4- fluorophenyl...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387483BDBM387483(US10294212, No. 108 | N3-(3-Chloro-4- fluorophenyl...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387468BDBM387468(US10294212, No. 96 | 7-Ethyl-N3-(3- ethynylphenyl)...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387466BDBM387466(US10294212, No. 95 | N3-(3-Chloro-4- fluorophenyl)...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387465BDBM387465(US10294212, No. 94 | N3-(3-Chloro-4- fluorophenyl)...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387473BDBM387473(US10294212, No. 100 | N3-(3-Chloro-4- fluorophenyl...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387470BDBM387470(US10294212, No. 98 | N3-(3-Chloro-4- fluorophenyl)...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387469BDBM387469(US10294212, No. 97 | N3-(3-Chloro-4- fluorophenyl)...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387498BDBM387498(US10294212, No. 120 | N3-(3- Fluorophenyl) benzo[b...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387497BDBM387497(US10294212, No. 119 | N3-(3- (Trifluoro- methyl)ph...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387492BDBM387492(US10294212, No. 117 | N3-(3-Chloro-4- fluorophenyl...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387505BDBM387505(US10294212, No. 124 | N3-(4-Chloro-3- (trifluoro- ...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387504BDBM387504(US10294212, No. 123 | 5-Bromo-N3-(3- chloro-4- flu...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387487BDBM387487(US10294212, No. 112 | 2-Amino-3-((3- chloro-4- flu...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387486BDBM387486(US10294212, No. 111 | N3-(3-Ethynyl- 4- fluorophen...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387485BDBM387485(US10294212, No. 110 | N3-(3-Ethynyl- 4- fluorophen...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387490BDBM387490(US10294212, No. 115 | 2-Amino-3-((3- bromophenyl) ...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387488BDBM387488(US10294212, No. 113 | 2-Amino-3-((3- (trifluoro- m...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387515BDBM387515(US10294212, No. 128 | N3-(4-Fluoro- 3-(trifluoro- ...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387431BDBM387431(US10294212, No. 153 | N3-(3-Chloro-4- fluorophenyl...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387559BDBM387559(US10294212, No. 152 | Methyl 4-(2- amino-3-((3- ch...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387558BDBM387558(US10294212, No. 151 | 4-(2-Amino-3- ((3-chloro-4- ...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387557BDBM387557(US10294212, No. 149 | 4-(2-Amino-3- ((3-chloro-4- ...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387561BDBM387561(US10294212, No. 154 | N3-(3- Chloro-4- fluoropheny...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387554BDBM387554(US10294212, No. 148 | N3-(3- Chloro-4- fluoropheny...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387553BDBM387553(US10294212, No. 147 | N3-(3- Chloro-4- fluoropheny...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387577BDBM387577(US10294212, No. 170 | N3-(3-chloro-4- fluorophenyl...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387576BDBM387576(US10294212, No. 169 | 4-(2-Amino-3- ((3-chloro-4- ...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387452BDBM387452(N3-(3-Chloro-4- fluorophenyl)- 5-methoxy-7- methyl...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387574BDBM387574(US10294212, No. 166 | 7-Chloro-N3- (3-chloro-4- fl...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Curadev Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 387581BDBM387581(US10294212, No. 174 | N3-(3-chloro-4- fluorophenyl...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasel (hIDO1) catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of tryptophan to yield N-formyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

Displayed 1 to 50 (of 277 total ) | Next | Last >>
Jump to: